This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Louise Koopman, PhD
Scientific Project Lead, Translational Research at Genmab

Profile

Louise Koopman currently leads the translational research efforts for the DuoBody® -CD3xB7H4 program at Genmab. Prior to Genmab, she worked at Celgene, Dana Farber Cancer Institute and Biogen, where she advanced novel antibody and small molecule drug candidates through pre-clinical research towards IND. She holds a MSc in Bio-Pharmaceutical Sciences and a PhD in Tumor Immunology/Pathology from the University of Leiden, and performed post-doctoral immunology research at Harvard University.

Agenda Sessions

  • In Vitro and In Vivo Studies Establish DuoBody®-CD3xB7H4 As a Novel Drug Candidate for the Treatment of Solid Cancers

    17:25